Roivant Sciences Ltd. (ROIV) stock
ROIVNasdaqPharmaceutical PreparationsFiscal year ends March 31
$38.66−0.30 (-0.78%)
Close on Nov 20, 2026Market cap $27.92BP/E –Yield –
Roivant Sciences gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
No gross profit figures for Roivant Sciences
Roivant Sciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?